Efficacy and Safety of Long-Term Ixazomib Maintenance Therapy in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Not Undergoing Transplant: An Integrated Analysis of Four Phase 1/2 Studies

Meletios A Dimopoulos,Jacob Laubach,Maria Asuncion Echeveste Gutierrez,Norbert Grząśko,Craig C Hofmeister,Jesus F San Miguel,Shaji K Kumar,Vickie Lu,Zhaoyang Teng,Guohui Liu,Catriona Byrne,Deborah Berg,Richard Labotka,Helgi Van De Velde,Paul G Richardson

doi:10.1182/blood.v130.suppl_1.902.902

Efficacy and Safety of Long-Term Ixazomib Maintenance Therapy in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Not Undergoing Transplant: An Integrated Analysis of Four Phase 1/2 Studies

Meletios A Dimopoulos, Jacob Laubach + Show 13 more

Open Access

https://doi.org/10.1182/blood.v130.suppl_1.902.902

Copy DOI

Journal: Blood	Publication Date: Dec 7, 2017
Citations: 4

Affiliation: National and Kapodistrian University of Athens, Dana-Farber Cancer Institute, Harvard University, Biodonostia, Medical University of Lublin, The Ohio State University, Mayo Clinic, Takeda (United States), Millennium Engineering and Integration (United States)

#Advisory Committees #Newly Diagnosed Multiple Myeloma Pts + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

Efficacy and Safety of Long-Term Ixazomib Maintenance Therapy in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Not Undergoing Transplant: An Integrated Analysis of Four Phase 1/2 Studies

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Blood

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.